Egis in the World

Egis is an international pharma company, its products reach 100 countries.

Click here to learn more

Pharma Company

Egis’ products reach 100 countries. Our portfolio consists of 653 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Click here to learn more

Research & Development

One of the fundamental pillars of our strategy is innovation. We devoted EUR 48 million to research and development in the 2022/2023 financial year.

Click here to learn more
Own subsidiaries / Representative offices
Sales through Partners
Events

Merry Christmas

May the spirit of Christmas bring you peace, love and happiness. Merry Christmas and Happy New Year!

More
Events

Happy Easter

May this joyful season of Easter fill your heart with renewed hope, love and peace. Happy Easter!

More
Events

Celebrating our company’s 110th anniversary

The predecessor of Egis Pharmaceuticals PLC, Dr Wander Pharmaceuticals and Nutriments Ltd. was registered on 19 February 1913.

More
More articles

Egis in the World

Egis' products reach 100 countries.

Egis’ products reach 100 countries. Our portfolio consists of 653 products.  Our main focus lies on treating diseases of the cardiovascular and central nervous systems.

Learn more

A place to work

Join us!

Healthcare Professionals

and prescription drugs

Professional content for our medical and pharmaceutical visitors. These contents are available with password protection - please contact our representative or require your own account at the Contact menu.

Learn more
Therapeutic areas
Therapeutic areas
Cardiovascular system
Central nervous system
Oncology
Women´s health
Gastroenterology
Dermatology
Diabetology
Rheumatology
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox